Vaccine News and Research

Latest Vaccine News and Research

HonorHealth begins trial of dendritic cell vaccine for advanced melanoma

Physicians at HonorHealth Research Institute have begun a clinical trial of a new, potentially more powerful, treatment for fighting advanced melanoma, using the immune system's dendritic cells to create a vaccine.

11 Aug 2026

New UH Health initiative targets Texas healthcare workforce shortage

Addressing Texas' growing healthcare workforce shortage and rising demand for care, the University of Houston has launched UH Health, an academic health enterprise designed to integrate education, research and community engagement across the University.

11 Aug 2026

H5N1 infections remain rare among workers exposed to infected birds

A two-year cohort study of 428 people exposed to H5N1-infected birds in England found fewer than 1% met criteria for infection, with no severe disease or secondary human transmission. The findings support continued PPE use, biosecurity, and targeted surveillance while highlighting challenges around occupational exposure, mucosal contamination, and pandemic preparedness.

10 Aug 2026

New combination therapy could permanently clear HIV in newborns

Every year, more than 120,000 newborns worldwide contract HIV, a global health burden that requires lifelong treatment for millions of people - assuming they have access and can afford it.

10 Aug 2026

Fridge-free vaccine shows promise for reaching millions more people worldwide

The world-first trial of a fridge-free tetanus-diphtheria vaccine at University Hospital Southampton (UHS) has produced encouraging results that could improve access worldwide to crucial treatments.

10 Aug 2026

Meningococcal B vaccine linked to lower gonorrhoea risk

The meningococcal B (MenB) vaccine could provide protection against more than one disease, with new research linking it to a significant reduction in the risk of gonorrhoea in young Territorians.

6 Aug 2026

Advances in DNA technology are reshaping preventive healthcare

A new review highlights how advances in DNA technology are reshaping the future of healthcare by shifting the focus from treatment to prevention.

6 Aug 2026

Long-acting HIV prevention tools could help close the gap before a vaccine arrives

A review of non-vaccine HIV interventions highlights the strong preventive effects of long-acting PrEP, sustained ART, U=U, vertical transmission programs, and voluntary medical male circumcision. Gene editing and multispecific antibodies may expand future options, but safety, cost, access, adherence, and implementation barriers remain.

5 Aug 2026

New website tracks vaccine preventable diseases across the United States

A new website will track the spread of vaccine-preventable diseases across the United States to offer the public, the media, healthcare providers, public health officials, and policymakers reliable and visual information about current disease trends.

5 Aug 2026

Persistent media skepticism shapes common vaccine conspiracy beliefs

A research team led by Professor Hitoshi Yamamoto of Rissho University analyzed five years of longitudinal panel survey data collected between 2020 and 2024 and examined how vaccine-related conspiracy beliefs were associated with media skepticism during the COVID-19 pandemic.

5 Aug 2026

Malaria infection causes permanent damage to the spleen immune cells

Macrophages formed in the bone marrow can only assume the function of embryonal phagocytes, or "scavenger cells," to a certain degree according to a study by the University of Bonn and the Peter Doherty Institute for Infection and Immunity at the University of Melbourne.

4 Aug 2026

Australian-first twin study aims to to unlock new insights into immune health

An Australian-first study of twins will seek to find out why two genetically similar people respond differently to infections, diseases and treatments.

4 Aug 2026

AI-driven optimization speeds large-scale vaccine distribution planning

Optimization models do an excellent job of ensuring products get where they are needed in the most efficient way possible, but those models require an impractical amount of computing power when dealing with large-scale problems – such as distributing vaccines to millions of people.

3 Aug 2026

Study reveals steep financial burden of New Mexico measles outbreak

A cost analysis of the 2025 measles outbreak in New Mexico found that the outbreak carried an estimated societal cost of $5.4 million, or more than $53,000 per case.

3 Aug 2026

Penn State study identifies genetic regions linked to avian herpesvirus virulence

A highly contagious herpes virus causes Marek's disease, a deadly illness that mainly infects chickens. While it does not make people sick, the virus causes tumors and paralysis in chickens and, if unchecked, can spread rapidly through entire flocks.

3 Aug 2026

Program introduces Florida students to virology and pandemic preparedness

Thirty outstanding high school students from 18 communities across Florida arrived in Tampa last week for the Global Virus Network (GVN) Global Guardians for Pandemic Preparedness Program, curious about viruses and considering careers in science.

30 Jul 2026

Ten-million-person study links semaglutide to lower COVID-19 mortality

Researchers analyzing claims from more than 10.1 million commercial insurance and Medicare Advantage enrollees found that semaglutide use was associated with a 49% lower adjusted hazard of COVID-19-related death. The observational findings corroborate earlier SELECT trial results but do not establish causation, making further prospective research essential.

30 Jul 2026

Research reveals how a hidden immune cell army defends human lung tissue

New research led by scientists at La Jolla Institute for Immunology (LJI) and University of Liverpool (UOL) provides the first comprehensive look at how a hidden immune cell army defends the vast, vulnerable tissue of the human lungs.

28 Jul 2026

Remdesivir protects kidney and heart health in transplant recipients

Adults with kidney transplants who were treated for COVID-19 with the antiviral remdesivir within a week of COVID-19 diagnosis and who received at least three consecutive days of therapy were less likely than kidney transplant recipients who did not receive the antiviral to experience cardiovascular or kidney problems up to a year later, according to findings from a target trial emulation study that published in JAMA Network Open.

28 Jul 2026

Europe risks missing target to eliminate viral hepatitis by 2030

While Europe has made steady progress in preventing hepatitis B and C, with the prevalence of hepatitis B now at near-zero levels among children below five years old, an uneven implementation of key measures means that the region is set to miss the 2030 target to eliminate viral hepatitis as a public health threat, according to new data from the European Centre for Disease Prevention and Control (ECDC) on World Hepatitis Day.

28 Jul 2026